Bexacat™ (Bexagliflozin) Tablets offers a noninsulin, needle-free, once-daily oral medication specifically designed for cats with diabetes mellitus.
- Sodium-glucose cotransporter 2 (SGLT2) inhibitor, this first-in-class therapeutic is indicated to improve glycemic control in otherwise healthy cats with diabetes mellitus not previously treated with insulin
- For oral use in cats only
- Minimal risk of hypoglycemia and no dosage changes during treatment
- Convenient, needle-free, once-daily flavored tablet ensures dosing certainty
- No dose titration needed
- No refrigeration required
- Can be given with or without food